Medifast (MED) Tops Q1 EPS by 17c

Medifast (NYSE: MED) reported Q1 EPS of ($0.19), $0.17 better than the analyst estimate of ($0.36). Revenue for the quarter came in at $76 million versus the consensus estimate of $85.5 million.

For earnings history and earnings-related data on Medifast (MED) click here.

You May Also Be Interested In

• LeonaBio (LONA) Price Target Cut to $17 by Citizens Amid Pipeline Development
• Allogene (ALLO) Reiterated at Market Outperform by Citizens: 'ALPHA3 Trial is On-Track'
• Keefe, Bruyette & Woods Downgrades Crescent BDC (CCAP) to Market Perform